| scholarly article | Q13442814 |
| P50 | author | Sagar Lonial | Q66431075 |
| P2093 | author name string | Jing Chen | |
| Sumin Kang | |||
| Ting-Lei Gu | |||
| Ailan Guo | |||
| Shaozhong Dong | |||
| Hong Ruan | |||
| Hanna Jean Khoury | |||
| P2860 | cites work | Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3 | Q22010472 |
| Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity | Q24679767 | ||
| 90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1. | Q27863657 | ||
| Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase | Q28283499 | ||
| Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo | Q28294928 | ||
| Regulation of transcription by MAP kinase cascades | Q29618477 | ||
| Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. | Q33690319 | ||
| Signal transduction via the MAP kinases: proceed at your own RSK. | Q36381460 | ||
| The search for physiological substrates of MAP and SAP kinases in mammalian cells | Q36914508 | ||
| FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway | Q39042319 | ||
| A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. | Q39922852 | ||
| Evidence for two catalytically active kinase domains in pp90rsk | Q40018405 | ||
| Structural bioinformatics-based design of selective, irreversible kinase inhibitors | Q40307105 | ||
| Ser-10 phosphorylation of histone H3 and immediate early gene expression in oncogene-transformed mouse fibroblasts | Q42820135 | ||
| A MAP kinase docking site is required for phosphorylation and activation of p90(rsk)/MAPKAP kinase-1. | Q48922580 | ||
| Thermally Switchable Periodicities and Diffraction from Mesoscopically Ordered Materials | Q57370347 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 4652-4657 | |
| P577 | publication date | 2007-12-21 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529. | |
| P478 | volume | 283 |
| Q24632768 | Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases |
| Q33584146 | Coordinating cellular events during spermatogenesis: a biochemical model |
| Q41910374 | Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation |
| Q35108153 | Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells. |
| Q37315384 | Hydrostatic pressure-dependent changes in cyclic AMP signaling in optic nerve head astrocytes from Caucasian and African American donors |
| Q52655388 | Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis. |
| Q30433106 | RSK in tumorigenesis: connections to steroid signaling |
| Q37694863 | RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics |
| Q48347255 | RSK2 drives cell motility by serine phosphorylation of LARG and activation of Rho GTPases |
| Q30423242 | RSK2 protein suppresses integrin activation and fibronectin matrix assembly and promotes cell migration |
| Q36212896 | Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240. |
| Q38895271 | Ribosomal S6 kinase (RSK) modulators: a patent review |
| Q37104693 | Ribosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signaling |
| Q39441370 | Selective Targeting of RSK Isoforms in Cancer |
| Q37802388 | Targeting RSK2 in human malignancies |
| Q28115584 | Tyrosines 868, 966, and 972 in the kinase domain of JAK2 are autophosphorylated and required for maximal JAK2 kinase activity |
| Q39162303 | p90 RSK2 mediates antianoikis signals by both transcription-dependent and -independent mechanisms |
| Q35083267 | p90RSK2 is essential for FLT3-ITD- but dispensable for BCR-ABL-induced myeloid leukemia. |
Search more.